Linked Life Data

11773163

Source:http://linkedlifedata.com/resource/pubmed/id/11773163

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-1-4
pubmed:abstractText
A strain of Salmonella typhimurium (VNP20009), attenuated by chromosomal deletion of the purI and msbB genes, was found to target to tumor and inhibit tumor growth in mice. These findings led to the present phase I study of the intravenous infusion of VNP20009 to patients with metastatic cancer.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-10837181, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-10936147, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-11015444, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-11145708, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-12616110, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-13214374, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-13801168, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-14925388, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-1737934, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-2822812, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-3356468, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-3513285, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-8983279, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-9377566, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-9399402, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-9400897, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-9720873, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-9831564, http://linkedlifedata.com/resource/pubmed/commentcorrection/11773163-9920266
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
142-52
pubmed:dateRevised
2011-9-15
pubmed:meshHeading
pubmed-meshheading:11773163-Adult, pubmed-meshheading:11773163-Aged, pubmed-meshheading:11773163-Antibodies, Bacterial, pubmed-meshheading:11773163-Antineoplastic Agents, pubmed-meshheading:11773163-Bacterial Translocation, pubmed-meshheading:11773163-Carcinoma, Renal Cell, pubmed-meshheading:11773163-Colony Count, Microbial, pubmed-meshheading:11773163-Cytokines, pubmed-meshheading:11773163-Dose-Response Relationship, Immunologic, pubmed-meshheading:11773163-Female, pubmed-meshheading:11773163-Genetic Engineering, pubmed-meshheading:11773163-Humans, pubmed-meshheading:11773163-Infusions, Intravenous, pubmed-meshheading:11773163-Male, pubmed-meshheading:11773163-Maximum Tolerated Dose, pubmed-meshheading:11773163-Melanoma, pubmed-meshheading:11773163-Middle Aged, pubmed-meshheading:11773163-Salmonella typhimurium
pubmed:year
2002
pubmed:articleTitle
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.
pubmed:affiliation
Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 2B42, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase I